Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 28Breast Diseases 3Advanced Breast Cancer 2Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Recurrence 1Obesity 1Nutrition Disorders 1Neoplasms 1Neoplasm Metastasis 1Inflammatory Breast Neoplasms 1Endometrial Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Camurati-Engelmann Syndrome 1Bulbo-Spinal Atrophy, X-Linked 1Breast Carcinoma In Situ 1Breast Cancer Organoids 1Arthritis 1Arthralgia 1

Interventions

Radiotherapy 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Camurati-Engelmann Syndrome × Anastrozole × Clear all
NCT01402193 2014-06-25

Study of Arimidex and Radiotherapy Sequencing

Fudan University

Phase 3 Unknown
220 enrolled
Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡